LOW:NYSELowe's Companies, Inc. Analysis
Data as of 2026-09-09 - not real-time
$200.80
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Lowe's Companies, Inc. trades at $200.80, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 5.1%. Relative strength is 37.4 — approaching oversold — and the MACD signal is bearish. Price has been bracketed by support at $199.34 and resistance at $225.79.
Valuation screens as undervalued, on a P/E of 17.0 with no clean sector comparison available. Analyst price targets sit 26.4% above the current price. Revenue is growing at 8.3% on a 7.3% profit margin. The 2.45% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 26.1%, a beta of 0.64 and a maximum drawdown of 30.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Valuation screens as undervalued, on a P/E of 17.0 with no clean sector comparison available. Analyst price targets sit 26.4% above the current price. Revenue is growing at 8.3% on a 7.3% profit margin. The 2.45% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 26.1%, a beta of 0.64 and a maximum drawdown of 30.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
Lowe’s Companies, Inc. NYSE:LOW delivered an earnings beat alongside weak organic growth and a reduced outlook....Updated Aug 19, 2026 0 — Diluted EPS of $4.Lowe’s Companies, Inc. NYSE:LOW ’s second-quarter results were a mixed bag. The company beat expectations on...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 236.14
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 236.14
- Analyst targets imply +26.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +26.4% versus the current price
- P/E ratio of 17.0
- Dividend yield of 2.45%
Key Metrics & Analysis
Financial Health
Revenue Growth8.30%
Profit Margin7.35%
P/E Ratio17.0
ROA12.52%
P/B Ratio-15.1
Op. Cash Flow$9.3B
Free Cash Flow$4.6B
Technical Analysis
TrendBearish
RSI37.4
Support$199.34
Resistance$225.79
MA 20$211.36
MA 50$212.90
MA 200$236.14
MACDBearish
VolumeStable
Fear & Greed Index93.36
Valuation
Fair Value$78.46
Target Price$253.76
Upside/Downside26.37%
GradeUndervalued
TypeBlend
Dividend Yield2.45%
Risk Assessment
Beta0.64
Volatility26.12%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.